Time is running out for some Walgreens shoppers to file for their part of a proposed class action settlement that accuses the pharmacy chain of overcharging for generic drugs.

Drug store chain reports revenue and adjusted earnings that topped estimates as it prepares to be taken private ...

Walgreens , which is in the process of being taken private by Sycamore Partners, beat Wall Street estimates for quarterly ...

Adjusted earnings came in at $0.63 per share for the three-month period ended Feb. 28, exceeding analyst expectations of ...

Those Walgreens shoppers will have until June ... This resolution allows us to focus on our turnaround strategy that will benefit our patients, customers, team members and shareholders.